Digital Therapeutics Market by Application and End User - Global Industry Analysis and Forecast to 2027
Published On : May 2022 Pages : 101 Category: Healthcare IT Report Code : HC0629
Industry Trend Analysis
The global digital therapeutics market is estimated to be around $9 billion by 2027. The market is expected to witness high growth during forecast period due to increase in demand for digitalization of healthcare and effective management of acute and chronic diseases. Besides rise in incidences of chronic diseases, technological up gradation, demand for preventive measures for management of diseases and rising demand for e-health will further drive the market growth. Increasing use of smartphones and growing number of internet users globally will significantly contribute to the growth of the market. Another vital factor responsible for the growth of digital therapeutics market is cost effectiveness of digital therapeutics as compared to traditional methods as it allows remote consultation to patients. Despite large investment in this segment, data privacy issues, lack of awareness about digital health programs and refusal from healthcare providers as well as patients will hamper the growth of the market.
Application Outlook and Trend Analysis
Diabetes segment is expected to witness highest growth over the forecast period, due to increase in prevalence of diabetes worldwide. According to the International Diabetes Federation (IDF), around 415 million people across globe were affected by diabetes as of 2017 and this number is expected to reach 642 million by 2040. Such a high prevalence of diabetes will primarily drive growth of the market. Preventive market segment is expected to witness fastest growth during forecast period. This can be attributed to factors such as increasing demand for pre-screening techniques for various chronic diseases and rise in demand for cost saving preventive healthcare programs.
Regional Outlook and Trend Analysis
North America accounted for the largest share of the global digital therapeutics market in 2017. This can be attributed to number of factors such as rise in elderly population requiring better healthcare facilities, presence of large number of digital therapy providers in the region, high rate of adoption of advanced medical devices and rise in demand for patient-centric healthcare procedures. Europe accounted for the second largest share of the global market in 2017 due to increase demand for digitalization of healthcare.
Asia-Pacific is expected to grow at fastest CAGR during forecast period owing to a number of factors such as increase in elderly population, changing healthcare infrastructure and increase in demand for cost saving screening and treatment techniques.
Competitive Insights
Product development facilitated through technological innovation is the major strategy adopted by the key players operating in the global digital therapeutics market. For instance, in January 2022, WellDoc, Inc. obtained FDA clearance for non-prescription version of their BlueStar digital therapeutic for patients suffering from type 2 diabetes.
Some of the major players operating in the global market are Proteus Digital Health, Omada Health, Inc., WellDoc Inc., 2Morrow, Inc., Livongo Health, Propeller Health, Twinehealth, Canary Health, Inc. Mango Health, Inc. and Noom, Inc.
Market opportunities
The digital therapeutics market will be driven by technologically advanced products over the coming years as demand for patient centric healthcare is on the rise globally. Digital therapeutics facilitates the intersection of science, design and technology to create market ready solutions that provide customized healthcare programs to the patients. Such developments will fuel the growth of this market over the forecast period.
Digital Therapeutics Market Segmentation:
By Application:
- Preventive
- Prediabetes
- Obesity
- Treatment/care
o Diabetes
o Medication Adherence
o Central Nervous System Disease
o Respiratory Diseases
o Musculoskeletal Diseases
o Smoking Cessation
o Cardiovascular Diseases
o Other Applications
By End User:
- Patients
- Employees
- Payers
- Providers
- Others
By Region:
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- Turkey
- United Arab Emirates
o Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2022 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
- Digital Therapeutics Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
- Preventive
- Prediabetes
- Obesity
- Treatment/Care
- Diabetes
- Medication Adherence
- Central Nervous System Disease
- Respiratory Diseases
- Musculoskeletal Diseases
- Smoking Cessation
- Cardiovascular Diseases
- Other Applications
- Digital Therapeutics Market, By End User, Estimates and Forecast, 2017-2027 ($Million)
- Patients
- Providers
- Payers
- Employees
- Others
- Digital Therapeutics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
- North America
- North America Digital Therapeutics Market, By Country
- North America Digital Therapeutics Market, By Application
- North America Digital Therapeutics Market, By End User
- U.S. Digital Therapeutics Market, By Application
- U.S. Digital Therapeutics Market, By End User
- Canada Digital Therapeutics Market, By Application
- Canada Digital Therapeutics Market, By End User
- Mexico Digital Therapeutics Market, By Application
- Mexico Digital Therapeutics Market, By End User
-
- Europe
- Europe Digital Therapeutics Market, By Country
- Europe Digital Therapeutics Market, By Application
- Europe Digital Therapeutics Market, By End User
- Germany Digital Therapeutics Market, By Application
- Germany Digital Therapeutics Market, By End User
- France Digital Therapeutics Market, By Application
- France Digital Therapeutics Market, By End User
- UK Digital Therapeutics Market, By Application
- UK Digital Therapeutics Market, By End User
- Italy Digital Therapeutics Market, By Application
- UK Digital Therapeutics Market, By End User
- Spain Digital Therapeutics Market, By Application
- Spain Digital Therapeutics Market, By End User
- Rest of Europe Digital Therapeutics Market, By Application
- Rest of Europe Digital Therapeutics Market, By End User
- Europe
-
- Asia-Pacific
- Asia-Pacific Digital Therapeutics Market, By Country
- Asia-Pacific Digital Therapeutics Market, By Application
- Asia-Pacific Digital Therapeutics Market, By End User
- Japan Digital Therapeutics Market, By Application
- Japan Digital Therapeutics Market, By End User
- China Digital Therapeutics Market, By Application
- China Digital Therapeutics Market, By End User
- Australia Digital Therapeutics Market, By Application
- Australia Digital Therapeutics Market, By End User
- India Digital Therapeutics Market, By Application
- India Digital Therapeutics Market, By End User
- South Korea Digital Therapeutics Market, By Application
- South Korea Digital Therapeutics Market, By End User
- Rest of Asia-Pacific Digital Therapeutics Market, By Application
- Rest of Asia-Pacific Digital Therapeutics Market, By End User
- Asia-Pacific
-
- Rest of the World
- Rest of the World Digital Therapeutics Market, By Country
- Rest of the World Digital Therapeutics Market, By Application
- Rest of the World Digital Therapeutics Market, By End User
- Brazil Digital Therapeutics Market, By Application
- Brazil Digital Therapeutics Market, By End User
- South Africa Digital Therapeutics Market, By Application
- South Africa Digital Therapeutics Market, By End User
- Saudi Arabia Digital Therapeutics Market, By Application
- Saudi Arabia Digital Therapeutics Market, By End User
- Turkey Digital Therapeutics Market, By Application
- Turkey Digital Therapeutics Market, By End User
- United Arab Emirates Digital Therapeutics Market, By Application
- United Arab Emirates Digital Therapeutics Market, By End User
- Others Digital Therapeutics Market, By Application
- Others Digital Therapeutics Market, By End User
- Rest of the World
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Rising Prevalence of Chronic Diseases Worldwide
3.3.1.2. Rise in Demand for Preventive Measures for Disease Management
3.3.1.3. Rise in Number of Smartphones and Internet Users
3.3.2. Restraints
3.3.2.1. Resistance from Healthcare Providers
3.3.2.2. Lack of Awareness about Digital Therapeutics
3.3.2.3. Data Privacy Issues
3.3.3. Opportunities
3.3.3.1. Technological Advancements to Design and Develop Innovative Solutions
3.4. Industry Trends
4. Digital Therapeutics Market, By Application
4.1. Introduction
4.2. Digital Therapeutics Market Assessment and Forecast, By Application, 2017-2027
4.3. Preventive
4.3.1. Global Market Assessment and Forecast, By Type, 2017-2027 ($Million)
4.3.2. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.3.3. Prediabetes
4.3.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.3.4. Obesity
4.3.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4. Treatment / Care
4.4.1. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
4.4.2. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.3. Diabetes
4.4.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.4. Cardiovascular Diseases
4.4.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.5. Central Nervous System Disease
4.4.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.6. Smoking Cessation
4.4.6.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.7. Respiratory Diseases
4.4.7.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.8. Musculoskeletal Diseases
4.4.8.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.9. Smoking Cessation
4.4.9.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.10. Medication Adherence
4.4.10.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.11. Other Applications
4.4.11.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5. Digital Therapeutics Market, By End User
5.1. Introduction
5.2. Digital Therapeutics Market Assessment and Forecast, By End User, 2017-2027
5.2.1. Patients
5.2.1.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.2.2. Providers
5.2.2.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.2.3. Payers
5.2.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.2.4. Employees
5.2.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.2.5. Other End Users
5.2.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6. Digital Therapeutics Market , By Region
6.1. Introduction
6.2. Digital Therapeutics Market Assessment and Forecast, By Region, 2017-2027 ($Million)
6.3. North America
6.3.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.3.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.3.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.3.3.1. U.S.
6.3.3.1.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.3.3.1.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.3.3.2. Canada
6.3.3.2.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.3.3.2.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.3.3.3. Mexico
6.3.3.3.1. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.3.3.3.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4. Europe
6.4.1.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.4.1.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.1.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.1.4. Germany
6.4.1.4.1. Market Assessment and Forecast, By Application ,2017-2027 ($Million)
6.4.1.4.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.1.5. France
6.4.1.5.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.1.5.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.1.6. UK
6.4.1.6.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.1.6.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.1.7. Italy
6.4.1.7.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.1.7.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.1.8. Spain
6.4.1.8.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.1.8.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.1.9. Russia
6.4.1.9.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.1.9.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.4.1.10. Rest of Europe
6.4.1.10.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.4.1.10.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5. Asia-Pacific
6.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.5.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.1. Japan
6.5.3.1.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3.1.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.2. China
6.5.3.2.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3.2.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.3. Australia
6.5.3.3.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3.3.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.4. India
6.5.3.4.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3.4.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.5. South Korea
6.5.3.5.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3.5.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.6. Taiwan
6.5.3.6.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3.6.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.5.3.7. Rest of Asia-Pacific
6.5.3.7.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.5.3.7.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6. Rest of the World
6.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
6.6.2. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.1. Brazil
6.6.3.1.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3.1.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.2. Turkey
6.6.3.2.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3.2.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.3. Saudi Arabia
6.6.3.3.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3.3.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.4. South Africa
6.6.3.4.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3.4.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.5. United Arab Emirates
6.6.3.5.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3.5.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
6.6.3.6. Others
6.6.3.6.1. Market Assessment and Forecast, By Application, 2017-2027 ($Million)
6.6.3.6.2. Market Assessment and Forecast, By End User, 2017-2027 ($Million)
7. Company Profiles
7.1. Proteus Digital Health
7.1.1. Business Overview
7.1.2. End User Portfolio
7.1.3. Strategic Developments
7.2. Omada Health, Inc.
7.2.1. Business Overview
7.2.2. End User Portfolio
7.2.3. Strategic Developments
7.3. WellDoc Inc.
7.3.1. Business Overview
7.3.2. End User Portfolio
7.3.3. Strategic Developments
7.4. 2Morrow, Inc.
7.4.1. Business Overview
7.4.2. End User Portfolio
7.4.3. Strategic Developments
7.5. Livongo Health
7.5.1. Business Overview
7.5.2. End User Portfolio
7.5.3. Strategic Developments
7.6. Propeller Health
7.6.1. Business Overview
7.6.2. End User Portfolio
7.6.3. Strategic Developments
7.7. Twinehealth
7.7.1. Business Overview
7.7.2. End User Portfolio
7.7.3. Strategic Developments
7.8. Canary Health, Inc.
7.8.1. Business Overview
7.8.2. End User Portfolio
7.8.3. Strategic Developments
7.9. Mango Health, Inc.
7.9.1. Business Overview
7.9.2. End User Portfolio
7.9.3. Strategic Developments
7.10. Noom, Inc.
7.10.1. Business Overview
7.10.2. End User Portfolio
7.10.3. Strategic Developments
List of Tables
Table 1.Global Digital Therapeutics Market, By Application ($Million), 2017-2025
Table 2.Preventive Market, By Application ($Million), 2017-2025
Table 3.Preventive Market, By Region ($Million), 2017-2025
Table 4.Prediabetes Market, By Region ($Million), 2017-2025
Table 5.Obesity Market, By Region ($Million), 2017-2025
Table 6.Treatment / Care Market, By Application ($Million), 2017-2025
Table 7.Treatment / Care Market, By Region ($Million), 2017-2025
Table 8.Diabetes Market, By Region ($Million), 2017-2025
Table 9.Cardiovascular Diseases Market, By Region ($Million), 2017-2025
Table 10.Central Nervous System Diseases Market, By Region ($Million), 2017-2025
Table 11.Respiratory Diseases Market, By Region ($Million), 2017-2025
Table 12.Respiratory Diseases Market, By Region ($Million), 2017-2025
Table 13.Smoking Cessation Market, By Region ($Million), 2017-2025
Table 14.Medication Adherence Market, By Region ($Million), 2017-2025
Table 15.Other Applications Market, By Region ($Million), 2017-2025
Table 16.Global Digital Therapeutics Market, By End User ($Million), 2017-2025
Table 17.Patients Market, By Region ($Million), 2017-2025
Table 18.Providers Market, By Region ($Million), 2017-2025
Table 19.Payers Market, By Region ($Million), 2017-2025
Table 20.Employess Market, By Region ($Million), 2017-2025
Table 21.Other End Users Market, By Region ($Million), 2017-2025
Table 22.North America Digital Therapeutics Market, By Country, 2017-2025 ($Million)
Table 23.North America Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 24.North America Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 25.U.S. Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 26.U.S. Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 27.Canada Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 28.Canada Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 29.Mexico Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 30.Mexico Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 31.Europe Digital Therapeutics Market, By Country, 2017-2025 ($Million)
Table 32.Europe Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 33.Europe Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 34.Germany Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 35.Germany Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 36.France Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 37.France Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 38.UK Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 39.UK Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 40.Italy Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 41.Italy Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 42.Spain Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 43.Spain Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 44.Russia Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 45.Russia Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 46.Rest of Europe Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 47.Rest of Europe Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 48.Asia-Pacific Digital Therapeutics Market, By Country, 2017-2025 ($Million)
Table 49.Asia-Pacific Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 50.Asia-Pacific Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 51.Japan Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 52.Japan Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 53.China Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 54.China Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 55.Australia Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 56.Australia Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 57.India Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 58.India Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 59.South Korea Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 60.South Korea Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 61.Taiwan Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 62.Taiwan Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 63.Rest of Asia-Pacific Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 64.Rest of Asia-Pacific Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 65.Rest of the World Digital Therapeutics Market, By Country, 2017-2025 ($Million)
Table 66.Rest of the World Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 67.Rest of the World Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 68.Brazil Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 69.Brazil Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 70.Turkey Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 71.Turkey Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 72.Saudi Arabia Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 73.Saudi Arabia Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 74.South Africa Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 75.South Africa Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 76.United Arab Emirates Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 77.United Arab Emirates Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 78.Others Digital Therapeutics Market, By Application, 2017-2025 ($Million)
Table 79.Others Digital Therapeutics Market, By End User, 2017-2025 ($Million)
Table 80.Proteus Digital Health: Key Strategic Developments, 2017-2017
Table 81.Omada Health, Inc.: Key Strategic Developments, 2017-2017
Table 82.WellDoc Inc.: Key Strategic Developments, 2017-2017
Table 83.2Morrow, Inc.: Key Strategic Developments, 2017-2017
Table 84.Livongo Health: Key Strategic Developments, 2017-2017
Table 85.Propeller Health: Key Strategic Developments, 2017-2017
Table 86.Twinehealth: Key Strategic Developments, 2017-2017
Table 87.Canary Health, Inc.: Key Strategic Developments, 2017-2017
Table 88.Mango Health, Inc.: Key Strategic Developments, 2017-2017
Table 89.Noom, Inc.: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Global Digital Therapeutics MarketShare, By Application, 2017 & 2025
Figure 2.Digital Therapeutics Market Share, By End User, 2017 & 2025
Figure 3.Digital Therapeutics Market, By Region, 2017 ($Million)
Figure 4.Proteus Digital Health: Net Revenues, 2017-2017 ($Million)
Figure 5.Proteus Digital Health: Net Revenue Share, By Segment, 2017
Figure 6.Proteus Digital Health: Net Revenue Share, By Geography, 2017
Figure 7.Omada Health, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 8.Omada Health, Inc.Net Revenue Share, By Segment, 2017
Figure 9.Omada Health, Inc.: Net Revenue Share, By Geography, 2017
Figure 10.WellDoc Inc.: Net Revenues, 2017-2017 ($Million)
Figure 11.WellDoc Inc.: Net Revenue Share, By Segment, 2017
Figure 12.WellDoc Inc.: Net Revenue Share, By Geography, 2017
Figure 13.2Morrow, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 14.2Morrow, Inc.: Net Revenue Share, By Segment, 2017
Figure 15.2Morrow, Inc.: Net Revenue Share, By Geography, 2017
Figure 16.Livongo Health: Net Revenues, 2017-2017 ($Million)
Figure 17.Livongo Health: Net Revenue Share, By Segment, 2017
Figure 18.Livongo Health: Net Revenue Share, By Geography, 2017
Figure 19.Propeller Health: Net Revenues, 2017-2017 ($Million)
Figure 20.Propeller Health: Net Revenue Share, By Segment, 2017
Figure 21.Propeller Health: Net Revenue Share, By Geography, 2017
Figure 22.Twinehealth: Net Revenues, 2017-2017 ($Million)
Figure 23.Twinehealth: Net Revenue Share, By Segment, 2017
Figure 24.Twinehealth: Net Revenue Share, By Geography, 2017
Figure 25.Canary Health, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 26.Canary Health, Inc.: Net Revenue Share, By Segment, 2017
Figure 27.Canary Health, Inc.: Net Revenue Share, By Geography, 2017
Figure 28.Mango Health, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 29.Mango Health, Inc.: Net Revenue Share, By Segment, 2017
Figure 30.Mango Health, Inc.: Net Revenue Share, By Geography, 2017
Figure 31 .Noom, Inc.: Net Revenues, 2017-2017 ($Million)
Figure 32.Noom, Inc.: Net Revenue Share, By Segment, 2017
Figure 33.Noom, Inc.: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|